Chemycal has been acquired by 3E

Learn More

Arkema France S.A. Challenges ECHA's Compliance Decision in Latest Appeal

Your substances


This news contains references also to other Substances

Arkema France S.A. has filed an appeal against the European Chemicals Agency (ECHA) regarding a follow-up decision on the company's compliance with a previous ECHA directive. The contested decision, issued on January 5, 2024, faults Arkema for partial non-compliance in conducting an extended one-generation reproductive toxicity study (EOGRTS) as required by ECHA's initial compliance check. Arkema disputes the decision on multiple legal grounds, including exceeding time limits, breaching legal principles, and faulty scientific assessment, and seeks annulment of the decision along with a refund of the appeal fee. This ongoing legal battle underscores the challenges and complexities of regulatory compliance within the EU chemicals regulation framework.



Related News